Submit Deal
All funds
Similar funds
Summary
ATEM Capital invests in innovations across the Life Sciences industry with promise to cure once-incurable diseases that help people live longer.
Deals Overview
Market Context
All Funds
Back to top
All rights reserved. Copyright © 2025 Datasite
Senior Management
Anton Gopka
CEO
Deals
Service Providers
Relationships
Portfolio (2)
Team
Sort
amolyt pharma
HQ - France
Biotechnology
16 Sep 2021
Investment Date
£ 57 M
Deal Value
triumvira immunologics
HQ - United States
Health Care Facilities
17 Mar 2022
£ 76 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy